Model Development and Temporal Validation of the Predictive Factors for Return to Work After Stroke Rehabilitation
Launched by CHANGI GENERAL HOSPITAL · Feb 19, 2025
Trial Information
Current as of August 20, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Background Return to work post stroke is a key milestone for many survivors of stroke; however, many cannot achieve this goal. Based on the previous work by Tay et al, independent predictive factors were identified for return to work post inpatient stroke rehabilitation. In further works by Koh and Tay with the same dataset put through different models such as LASSO-Full, Lasso-Routine, ElasticNet-Full, etc suggests that the good discrimination performance of the return-to-work prediction models during internal validation supports a multisite, external validation study. Performing a tempora...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Completed inpatient stroke rehabilitation in CGH
- • 2. Diagnosis of a first ever stroke
- • 3. Patients who were working prior to stroke
- • 4. Consent given
- Exclusion Criteria:
- • 1. Not first ever stroke
- • 2. Did not require inpatient stroke rehabilitation
- • 3. Not working prior to stroke
- • 4. No consent obtained
About Changi General Hospital
Changi General Hospital (CGH) is a leading tertiary healthcare institution in Singapore, renowned for its commitment to providing high-quality patient care and advancing medical research. As a sponsor of clinical trials, CGH leverages its state-of-the-art facilities and multidisciplinary expertise to facilitate innovative research that aims to enhance treatment options and improve patient outcomes. The hospital is dedicated to upholding rigorous ethical standards and regulatory compliance while fostering collaboration with healthcare professionals and researchers to drive advancements in medical science. Through its clinical trials, CGH seeks to contribute to the global body of knowledge and translate research findings into practical applications for better healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported